(Q36832526)

16 August 2017

1 reference

title

Role of complement in antiphospholipid antibody-mediated thrombosis (English)

1 reference

16 August 2017

Kathleen M O'Neil

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Current Rheumatology Reports

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

205-211

1 reference

Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0033-Y

A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0033-Y

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0033-Y

Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome

21 January 2018

1 reference

12 December 2020

C5a induces tissue factor activity on endothelial cells

1 reference

12 December 2020

Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies

1 reference

12 December 2020

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

1 reference

12 December 2020

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion

1 reference

12 December 2020

Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep

1 reference

12 December 2020

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

1 reference

12 December 2020

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

1 reference

12 December 2020

Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors.

1 reference

12 December 2020

Anticardiolipin antibody and complement

1 reference

12 December 2020

Homozygous complement factor deficiency and primary antiphospholipid syndrome: a clinical and serological study.

1 reference

12 December 2020

Platelet C4d is highly specific for systemic lupus erythematosus

1 reference

12 December 2020

Detection of complement-fixing antiphospholipid antibodies in association with thrombosis

1 reference

12 December 2020

High frequency of C4 "null" alleles in primary antiphospholipid syndrome

1 reference

12 December 2020

Activation of complement mediates antiphospholipid antibody-induced pregnancy loss

1 reference

12 December 2020

Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia

1 reference

12 December 2020

Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis

1 reference

12 December 2020

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo

1 reference

12 December 2020

Placental pathology in systemic lupus erythematosus: a prospective study

1 reference

12 December 2020

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro

1 reference

12 December 2020

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

12 December 2020

Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype

1 reference

12 December 2020

Complement activation by anticardiolipin antibodies

1 reference

12 December 2020

Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis

1 reference

12 December 2020

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

1 reference

12 December 2020

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

1 reference

12 December 2020

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia

1 reference

12 December 2020

Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

12 December 2020

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

1 reference

12 December 2020

A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice

1 reference

12 December 2020

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

1 reference

12 December 2020

A critical role for murine complement regulator crry in fetomaternal tolerance

1 reference

12 December 2020

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

1 reference

12 December 2020

Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome

1 reference

12 December 2020

TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss

1 reference

12 December 2020

Antiphospholipid antibodies and complement activation in patients with cerebral ischemia

1 reference

12 December 2020

Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice

1 reference

12 December 2020

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

12 December 2020

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

12 December 2020

Antiphospholipid antibody-dependent C5b-9 formation

1 reference

12 December 2020

Mechanisms of autoantibody-induced monocyte tissue factor expression

1 reference

12 December 2020

Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice

1 reference

12 December 2020

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

12 December 2020

10.1007/S11926-007-0033-Y

Identifiers

DOI

1 reference

16 August 2017

1 reference